Home » Stocks » Bruker

Bruker Corporation (BRKR)

Stock Price: $43.99 USD 0.02 (0.05%)
Updated Aug 13, 2020 4:00 PM EDT - Market closed
After-hours: $43.88 -0.11 (-0.24%) Aug 13, 4:11 PM

Stock Price Chart

Key Info

Market Cap 6.73B
Revenue (ttm) 1.97B
Net Income (ttm) 164.50M
Shares Out 153.08M
EPS (ttm) 1.05
PE Ratio 41.90
Forward PE 39.53
Dividend $0.16
Dividend Yield 0.36%

Stock Quote

Trading Day Aug 13, 2020
Last Price $43.99
Previous Close $43.97
Change ($) 0.02
Change (%) 0.05%
Day's Open 43.89
Day's Range 43.46 - 44.17
Day's Volume 222,167
52-Week Range 30.78 - 54.49

More Stats

Market Cap 6.73B
Enterprise Value 7.00B
Earnings Date (est) Oct 29, 2020
Ex-Dividend Date May 29, 2020
Shares Outstanding 153.08M
Float 102.11M
EPS (basic) 1.07
EPS (diluted) 1.05
FCF / Share 0.98
Dividend $0.16
Dividend Yield 0.36%
Earnings Yield 2.39%
FCF Yield 2.24%
Payout Ratio n/a
Shares Short 2.92M
Short Ratio 4.65
Short % of Float 3.77%
Beta 1.38
PE Ratio 41.90
Forward PE 39.53
P/FCF Ratio 44.60
PS Ratio 3.42
PB Ratio 7.44
Revenue 1.97B
Operating Income 259.80M
Net Income 164.50M
Free Cash Flow 151.00M
Net Cash -270.50M
Net Cash / Share -1.77
Gross Margin 50.80%
Operating Margin 13.19%
Profit Margin 8.40%
FCF Margin 7.67%
ROA 6.03%
ROE 18.36%
ROIC n/a
Stats based on trailing-twelve-month (ttm) numbers.

Analyst Summary

Analyst Ratings (14)

Buy 5
Overweight 0
Hold 8
Underweight 0
Sell 1

Analyst Consensus: Overweight

Price Target

$47.92*
(8.93% upside)
Low
43.0
Current: $43.99
High
54.0
Target: 47.92
*Average 12-month price target from 13 stock analysts.

Financial Performance

Financial numbers in millions USD.

Financial Overview

Year2019201820172016201520142013201220112010
Revenue2,0731,8961,7661,6111,6241,8091,8391,7911,6521,305
Revenue Growth9.34%7.34%9.59%-0.77%-10.23%-1.66%2.68%8.46%26.58%-
Gross Profit995900816745709763805829753604
Operating Income301262220182146105148156159156
Net Income19718078.6015410256.7080.1077.5092.3095.40
Shares Outstanding155156158161168168167166165164
Earnings Per Share1.261.140.490.950.600.330.480.460.550.58
EPS Growth10.53%132.65%-48.42%58.33%81.82%-31.25%4.35%-16.36%-5.17%-
Dividend Per Share0.160.160.160.16------
Dividend Growth0%0%0%-------
Operating Cash Flow21324015413122911414513387.70156
Capital Expenditures-62.00-48.80-32.20-36.00-33.30-30.70-48.90-69.50-54.40-29.20
Free Cash Flow15119112294.8019683.6096.1063.6033.30127
Cash & Equivalents685322439500468498439311246233
Total Debt860341416412266355355337303301
Net Cash / Debt-175-18.7023.6088.6020314383.70-26.60-57.10-67.70
Assets2,7722,1291,9491,8081,7301,8651,9881,8561,7111,550
Liabilities1,8541,2241,2151,1159971,0931,1381,1471,0861,022
Book Value907897725686726766846707622525
Numbers in millions USD, except per-share numbers.

Company Profile

Company Details

Full Name Bruker Corporation
Country United States
Employees 7,000
CEO Frank H. Laukien

Stock Information

Ticker Symbol BRKR
Stock Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Unique Identifier NASDAQ: BRKR
IPO Date August 4, 2000

Description

Bruker Corporation manufactures and distributes scientific instruments, and analytical and diagnostic solutions in the United States, Europe, the Asia Pacific, and internationally. The company operates in three segments: Bruker Scientific Instruments (BSI) Life Science, BSI NANO, and Bruker Energy & Supercon Technologies. It offers life science tools based on magnetic resonance technology; life science mass spectrometry and ion mobility spectrometry solutions; analytical and process analysis instruments and solutions based on infrared and Raman molecular spectroscopy technologies; and radiological/nuclear detectors for chemical, biological, radiological, nuclear, and explosive detection The company also provides X-ray instruments, atomic force microscopy instrumentation, fluorescence optical microscopy instruments, analytical tools for electron microscopes and X-ray metrology, defect-detection equipment for semiconductor process control, and spark optical emission spectroscopy systems, as well as handheld, portable, and mobile X-ray fluorescence spectrometry instruments. In addition, it offers superconducting and non-superconducting materials and devices. The company serves pharmaceutical, biotechnology, and diagnostics companies; chemical, food and beverage, clinical, and polymer companies; nonprofit laboratories; contract research organizations, academic institutions, medical schools, nonprofit or for-profit forensics, environmental and clinical microbiology laboratories, and hospitals and government departments and agencies, as well as agriculture, and food and beverage safety companies; nanotechnology, semiconductor, and industrial companies; and raw material manufacturers and other businesses through direct sales forces, distributors, independent sales representatives, and other representatives. Bruker Corporation has collaboration with Inscopix. Bruker Corporation was incorporated in 1991 and is headquartered in Billerica, Massachusetts.